PART I Item 1. Bu siness. Overview VivoSim Labs, Inc., formerly known as Organovo Holdings, Inc. ("VivoSim," we, us, our, the Company and our Company), is a pharmaceutical and biotechnology services company that is focused on providing testing of drugs and drug candidates in three-dimensional (3D) human tissue models of liver and intestine. We offer partners liver and intestinal toxicology insights using our new approach methodologies ("NAM") models. We anticipate accelerated adoption of human t...
Q2 FY2026 — expected 2026-08-15
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-06-05 | 2025-03-31 | 0000950170-25-082312 | EDGAR | 50K words |
| 2024-05-31 | 2024-03-31 | 0000950170-24-067301 | EDGAR | — |
| 2023-07-14 | 2023-03-31 | 0000950170-23-032889 | EDGAR | — |
| 2022-06-10 | 2022-03-31 | 0001564590-22-022994 | EDGAR | — |
| 2021-06-15 | 2021-03-31 | 0001564590-21-032980 | EDGAR | — |
| 2020-05-28 | 2020-03-31 | 0001564590-20-027310 | EDGAR | — |
| 2019-06-03 | 2019-03-31 | 0001564590-19-021444 | EDGAR | — |
| 2018-05-31 | 2018-03-31 | 0001564590-18-014814 | EDGAR | — |
| 2017-06-07 | 2017-03-31 | 0001564590-17-012240 | EDGAR | — |
| 2016-06-09 | 2016-03-31 | 0001564590-16-020442 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-11 | 2025-12-31 | 0001193125-26-046520 | EDGAR | 40K words |
| 2025-11-06 | 2025-09-30 | 0001193125-25-269483 | EDGAR | — |
| 2025-08-12 | 2025-06-30 | 0000950170-25-107284 | EDGAR | — |
| 2025-02-19 | 2024-12-31 | 0000950170-25-022778 | EDGAR | — |
| 2024-11-08 | 2024-09-30 | 0000950170-24-124044 | EDGAR | — |
| 2024-08-05 | 2024-06-30 | 0000950170-24-090726 | EDGAR | — |
| 2024-02-08 | 2023-12-31 | 0000950170-24-012754 | EDGAR | — |
| 2023-11-09 | 2023-09-30 | 0000950170-23-062228 | EDGAR | — |
| 2023-08-10 | 2023-06-30 | 0000950170-23-041307 | EDGAR | — |
| 2023-02-09 | 2022-12-31 | 0000950170-23-002327 | EDGAR | — |
| 2022-11-10 | 2022-09-30 | 0001564590-22-037381 | EDGAR | — |
| 2022-08-11 | 2022-06-30 | 0001564590-22-029133 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-04-03 | 0001193125-26-142106 | EDGAR | 3K words |
| 2025-12-18 | 0001193125-25-324794 | EDGAR | — |
| 2025-08-14 | 0000950170-25-108447 | EDGAR | — |
| 2025-05-06 | 0000950170-25-063979 | EDGAR | — |
| 2025-04-24 | 0000950170-25-057685 | EDGAR | — |
| 2025-04-23 | 0000950170-25-056974 | EDGAR | — |
| 2025-04-02 | 0000950170-25-048888 | EDGAR | — |
| 2025-03-27 | 0000950170-25-045740 | EDGAR | — |
| 2025-03-26 | 0000950170-25-044801 | EDGAR | — |
| 2025-03-21 | 0000950170-25-042903 | EDGAR | — |
298 total filings indexed. 266 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001497253 |
| Ticker | VIVS |
| Exchange | Nasdaq |
| SIC | 2836: Biological Products, (No Diagnostic Substances) |
| Incorporated | DE |
| Website | https://www.organovo.com |
| Listed | 2011-08-16 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report